| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |